319.14
前日終値:
$319.87
開ける:
$319.23
24時間の取引高:
1.58M
Relative Volume:
0.59
時価総額:
$122.35B
収益:
$25.27B
当期純損益:
$3.34B
株価収益率:
36.97
EPS:
8.6334
ネットキャッシュフロー:
$4.57B
1週間 パフォーマンス:
-3.71%
1か月 パフォーマンス:
+3.68%
6か月 パフォーマンス:
-11.25%
1年 パフォーマンス:
-18.04%
Stryker Corp Stock (SYK) Company Profile
Compare SYK vs ABT, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
SYK
Stryker Corp
|
319.14 | 122.35B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
ABT
Abbott Laboratories
|
101.66 | 177.07B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
83.29 | 106.61B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
43.77 | 65.06B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.00 | 48.94B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-13 | 開始されました | Leerink Partners | Outperform |
| 2026-02-20 | 開始されました | William Blair | Outperform |
| 2026-01-27 | 再開されました | TD Cowen | Hold |
| 2026-01-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | 開始されました | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | 再開されました | Citigroup | Buy |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | 開始されました | Wolfe Research | Outperform |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-22 | アップグレード | Needham | Hold → Buy |
| 2024-01-31 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | 開始されました | ROTH MKM | Buy |
| 2023-09-05 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-25 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-28 | アップグレード | Edward Jones | Hold → Buy |
| 2022-07-21 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-07-11 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-04-13 | 開始されました | Truist | Hold |
| 2022-03-16 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | 再開されました | Evercore ISI | Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | 開始されました | Loop Capital | Buy |
| 2021-09-14 | 再開されました | Raymond James | Mkt Perform |
| 2021-07-28 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-05-25 | 開始されました | Barclays | Underweight |
| 2020-10-06 | 開始されました | Northland Capital | Market Perform |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-13 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2020-04-01 | ダウングレード | Goldman | Buy → Sell |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-08 | 開始されました | SunTrust | Hold |
| 2020-01-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | 繰り返されました | BTIG Research | Buy |
| 2019-11-05 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-10-30 | 繰り返されました | BofA/Merrill | Buy |
| 2019-07-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-30 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2019-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-08-16 | 開始されました | BTIG Research | Buy |
| 2018-06-27 | 開始されました | Bernstein | Mkt Perform |
| 2018-04-27 | 繰り返されました | Stifel | Buy |
すべてを表示
Stryker Corp (SYK) 最新ニュース
Stryker stock builds on earnings momentum after 16 July 2026 update - Ad-hoc-news.de
Stryker stock trades on its latest reported growth - ad-hoc-news.de
Mako Handheld Robotic Knee System Launch Might Change The Case For Investing In Stryker (SYK) - Yahoo Finance
Is Stryker Corp (SYK) a Bargain After 3.4% Drop? GF Value Says U - GuruFocus
Stryker Corp. stock underperforms Friday when compared to competitors - MarketWatch
Stryker Corp Stock (SYK) Moved Down by 3.42% on Jul 17: A Full Analysis - TradingKey
Stryker stock trades near highs as robotics and trauma growth support valuation - ad-hoc-news.de
Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio - The Globe and Mail
Stryker Corp (XTER:SYK) Stock Price, Trades & News - GuruFocus
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker (SYK) Launches Mako RPS Handheld Robot for Knee Replacem - GuruFocus
Stryker Shares Rise After Commercial Launch of Mako Robotic Power System - Moomoo
Stryker (SYK) Introduces Mako RPS for Total Knee Replacements - GuruFocus
Stryker launches Mako RPS handheld robotic knee system in U.S. - Investing.com
Stryker expands Mako robotics portfolio with full market release of Mako RPS - Finviz
Stryker Reports More Than 2.5M Mako Procedures in 47 Countries - Stock Titan
Stryker's quarterly earnings preview: What you need to know - MSN
Stryker Corp. stock underperforms Tuesday when compared to competitors - MSN
Stryker Corp (SYK) Stock Down 6.2% -- Now Undervalued? GF Score: 92/100 - GuruFocus
Goldman Sachs Adjusts Price Target on Stryker to $339 From $363, Maintains Neutral Rating - Moomoo
Stryker Corp Stock (SYK) Moved Down by 5.49% on Jul 14: A Full Analysis - TradingKey
Fund Update: 43,404 STRYKER (SYK) shares added to Douglas Lane & Associates, LLC portfolio - Quiver Quantitative
Stryker Slides As Investors Reassess Cyberattack Recovery Ahead Of Q2 Results - Quiver Quantitative
RBC Capital Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $435 - Moomoo
BTIG Research Adjusts Stryker Price Target to $371 From $379, Maintains Buy Rating - Moomoo
Disposable Endoscopes Market Size Projected to Hit USD 10.47 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Piper Sandler reiterates Stryker stock rating on Mako strength - Investing.com
Piper Sandler reiterates Stryker stock rating on Mako strength By Investing.com - Investing.com Canada
Stryker Corp Stock Operating Data - GuruFocus
Stryker Corp (FRA:SYK0) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Stryker (FRA:SYK0) Interest Paid - GuruFocus
Stryker Corp (FRA:SYK0) Competitors 2026 - GuruFocus
Stryker Corp (FRA:SYK0) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Stryker Corp (FRA:SYK0) Stock Price & 30 Year Financial Data - GuruFocus
Stryker Corp (FRA:SYK0) Valuation: Modestly Undervalued - GuruFocus
FRA:SYK0 Dividend: Does Stryker Corp Pay a Dividend? - GuruFocus
Stryker Corp (FRA:SYK0) Stock Earnings Transcripts - GuruFocus
Stryker Corp Stock Warning Signs - GuruFocus
Who's Buying or Selling Stryker Corp (FRA:SYK0) Stock Today? - GuruFocus
Stryker Corp (FRA:SYK0) Stock News, Headlines & Updates - GuruFocus
Argus raises Stryker stock price target on cyberattack recovery By Investing.com - Investing.com Australia
Argus raises Stryker stock price target on cyberattack recovery - Investing.com
Inside medtech’s cameo run on HBO Max’s ‘The Pitt’ - Modern Healthcare
Argus Research Maintains Stryker Corp(SYK.US) With Buy Rating, Cuts Target Price to $370 - Moomoo
Stryker's Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
Mixed Drivers Fuel Optimism in Stryker Corporation’s (SYK) Performance - Insider Monkey
SYK Initiates Coverage On Stryker -- Price Target Announced at $369 - GuruFocus
Argus Research Adjusts Stryker Price Target to $370 From $350 - Moomoo
Global Orthopedic Surgical Robots Market Report Published — Profiles Stryker, Zimmer Biomet, DePuy Synthes, and Medtronic - Yahoo Finance
Stryker Corp. focuses on innovation as medical device demand grows - AD HOC NEWS
Citi Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $385 - Moomoo
Stryker Corp (SYK) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):